These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 1089719)

  • 1. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immune response to sheep red blood cells on plasmacytoma MOPC 104 E.
    Ghanta VK; Hiramoto NS; Hiramoto RN
    Cancer Res; 1981 Jun; 41(6):2197-9. PubMed ID: 7237419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
    Cerny J; Waner EB
    J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
    Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
    Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
    Mathur A; Lynch RG
    J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of antibody response to SRBC. II. Effect of a non-specific stimulation.
    Ríhová B; Ríha I; Hofman J
    Folia Biol (Praha); 1981; 27(1):15-27. PubMed ID: 7009228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the primary IgM response to GAT and GT: conditions required for the detection of IgM antibodies.
    Waltenbaugh C; Dessein A; Benacerraf B
    J Immunol; 1979 Jan; 122(1):27-33. PubMed ID: 84020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte surface membrane immunoglobulin in myeloma. II. T cells with IgA-Fc receptors are markedly increased in mice with IgA plasmacytomas.
    Hoover RG; Lynch RG
    J Immunol; 1980 Sep; 125(3):1280-8. PubMed ID: 6967897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface immunoglobulins on circulating lymphocytes in mouse and human plasmacytoma.
    Heller P; Yakulis V; Bhoopalam N; Costea N; Cabana V; Nathan RD
    Trans Assoc Am Physicians; 1972; 85():192-202. PubMed ID: 4633774
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy.
    Adler A; Keisari Y; Ofir R
    J Natl Cancer Inst; 1985 Feb; 74(2):429-36. PubMed ID: 3856051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1449-55. PubMed ID: 15035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro.
    Mahony J; Bose A; Cowdrey D; Nusair T; Lei M; Harris J; Marks A; Baumal R
    J Immunol; 1981 Jan; 126(1):113-7. PubMed ID: 7451962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
    Reinertsen JL; Steinberg AD
    J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
    Nio Y; Ohgaki K; Tobe T
    J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth of MOPC 104E cells in immunosuppressed mice.
    Hiramoto RN; Cox PJ; Hiramoto NS; Ghanta VK
    J Immunol; 1984 Dec; 133(6):3424-8. PubMed ID: 6386985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of antibody release from single cells. 3. Rate of release of IgM from MOPC 104E plasmacytoma.
    Ghanta VK; McGhee JR; Hamlin NM; Hiramoto RN
    J Immunol; 1974 Jan; 112(1):266-70. PubMed ID: 4590822
    [No Abstract]   [Full Text] [Related]  

  • 19. Bispecific cells among IgM and IgG producers during the early phase of primary and secondary responses.
    Couderc J; Birrien JL; Oriol R; Bleux C; Liacopoulos P
    Eur J Immunol; 1975 Feb; 5(2):140-7. PubMed ID: 1241945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to liposomal model membranes: restricted IgM and IgG anti-dinitrophenyl antibodies produced in guinea pigs.
    Uemura K; Claflin JL; Davie JM; Kinsky SC
    J Immunol; 1975 Mar; 114(3):958-61. PubMed ID: 1089729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.